Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study (Supplemental File)

Name: Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study (Supplemental File)
Creator: Maria Asdourian
Published: 2022-07-07T18:57:17.160Z
Keywords: Dermatology, Oncology, Cancer Treatment, Chemotherapy, Adverse Event, Targeted Therapy, Medical Dermatology, Immune Checkpoint Blockade, Immune Checkpoint Inhibitor

Asdourian, Maria; Jacoby, Ted; Shah, Nishi; Thompson, Leah; Otto, Tracey; Semenov, Yevgeniy; LeBoeuf, Nicole; Reynolds, Kerry; Dewan, Anna; Chen, Steven

doi:10.17632/ncsbbw5xjk.1

Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study (Supplemental File)

Published: 7 July 2022| Version 1 | DOI: 10.17632/ncsbbw5xjk.1

Contributors:

Maria Asdourian, Ted Jacoby, Nishi Shah, Leah Thompson, Tracey Otto, Yevgeniy Semenov, Nicole LeBoeuf, Kerry Reynolds, Anna Dewan, Steven Chen

Description

This file includes additional methodological details and data.

Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study (Supplemental File)

Description

Files

Categories

Licence